XOMA, Ltd. (NASDAQ: XOMA) is focused on the discovery and development of antibodies, one of the most powerful and transformative fields of drug innovation today. By building on its pioneering proprietary pipeline, antibody discovery and development platform, and multiple revenue streams, the company is creating novel human antibody therapeutics that could revolutionize medicine and reshape people’s lives. For further information, visit the Company’s web site at www.xoma.com.
- 17 years ago
QualityStocks
XOMA, Ltd. (NASDAQ: XOMA)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – AI-Driven Energy Demands Highlight Strategic Value of Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project
As the rise of AI-generated services places extreme pressure on the global power grid, Platinum Group…
-
QualityStocksNewsBreaks – Spotlight on ONAR Holding Corp.’s (ONAR) Strategic Playbook: AI-Optimized Campaigns
ONAR (OTCQB: ONAR) was featured in a recent article that discussed its strategy amid the AI…
-
QualityStocksNewsBreaks – Why AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
AI Maverick Intel (OTCID: BINP) recently rebranded and adopted a new strategic direction focused on…